IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishThe glioblastoma (GBM) immune microenvironment is highly heterogeneous, and microglia may represent 30–70% of the entire tumor. However, the role of microglia and other specific immune populations is poorly characterized. Activation of mTOR signaling occurs in numerous human cancers and has roles in microglia-glioma cell interactions. We now show in human tumor specimens (42 patients), that 39% of tumor-associated microglial (TAM) cells express mTOR phosphorylated at Ser-2448; and similar mTOR activation is observed using a human microglia-glioma interaction paradigm. In addition, we confirm previous studies that microglia express urea and ARG1 (taken as M2 marker) in the presence of glioma cells, and this phenotype is down-regulated in the presence of a mTOR inhibitor. These results suggest that mTOR suppression in GBM patients might induce a reduction of the M2 phenotype expression in up to 40% of all TAMs. Since the M2 profile of microglial activation is believed to be associated with tumor progression, reductions in that phenotype may represent an additional anti-tumor mechanism of action of mTOR inhibitors, along with direct anti-proliferative activities.
Lisi, L., Ciotti, G. M. P., Chiavari, M., Pizzoferrato, M., Mangiola, A., Kalinin, S., Feinstein, D. L., Navarra, P., Phospho-mTOR expression in human glioblastoma microglia-macrophage cells, <<NEUROCHEMISTRY INTERNATIONAL>>, 2019; 129 (na): 104485-147797. [doi:10.1016/j.neuint.2019.104485] [http://hdl.handle.net/10807/147635]
| Autori: | ||
| Titolo: | Phospho-mTOR expression in human glioblastoma microglia-macrophage cells | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.neuint.2019.104485 | |
| URL: | www.elsevier.com/locate/neuint | |
| Data di pubblicazione: | 2019 | |
| Abstract: | The glioblastoma (GBM) immune microenvironment is highly heterogeneous, and microglia may represent 30–70% of the entire tumor. However, the role of microglia and other specific immune populations is poorly characterized. Activation of mTOR signaling occurs in numerous human cancers and has roles in microglia-glioma cell interactions. We now show in human tumor specimens (42 patients), that 39% of tumor-associated microglial (TAM) cells express mTOR phosphorylated at Ser-2448; and similar mTOR activation is observed using a human microglia-glioma interaction paradigm. In addition, we confirm previous studies that microglia express urea and ARG1 (taken as M2 marker) in the presence of glioma cells, and this phenotype is down-regulated in the presence of a mTOR inhibitor. These results suggest that mTOR suppression in GBM patients might induce a reduction of the M2 phenotype expression in up to 40% of all TAMs. Since the M2 profile of microglial activation is believed to be associated with tumor progression, reductions in that phenotype may represent an additional anti-tumor mechanism of action of mTOR inhibitors, along with direct anti-proliferative activities. | |
| Lingua: | Inglese | |
| Rivista: | ||
| Citazione: | Lisi, L., Ciotti, G. M. P., Chiavari, M., Pizzoferrato, M., Mangiola, A., Kalinin, S., Feinstein, D. L., Navarra, P., Phospho-mTOR expression in human glioblastoma microglia-macrophage cells, <<NEUROCHEMISTRY INTERNATIONAL>>, 2019; 129 (na): 104485-147797. [doi:10.1016/j.neuint.2019.104485] [http://hdl.handle.net/10807/147635] | |
| Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
| File | Descrizione | Tipologia | Note | Licenza | |
|---|---|---|---|---|---|
| NI mtor microglia e glioma 2019.pdf | Versione Editoriale (PDF) | Nessuna Nota |  | Open Access Visualizza/Apri |
Copyright © 2022